- Home
- CUE vs STEM Comparison
CUE vs STEM Comparison
Compare CUE & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- STEM
- Stock Information
- Founded
- CUE 2014
- STEM 2009
- Country
- CUE United States
- STEM United States
- Employees
- CUE N/A
- STEM N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- STEM Computer Software: Prepackaged Software
- Sector
- CUE Health Care
- STEM Technology
- Exchange
- CUE Nasdaq
- STEM Nasdaq
- Market Cap
- CUE 60.6M
- STEM 72.0M
- IPO Year
- CUE 2018
- STEM N/A
- Fundamental
- Price
- CUE $0.92
- STEM $0.39
- Analyst Decision
- CUE Strong Buy
- STEM Hold
- Analyst Count
- CUE 4
- STEM 9
- Target Price
- CUE $4.75
- STEM $1.11
- AVG Volume (30 Days)
- CUE 151.6K
- STEM 3.9M
- Earning Date
- CUE 05-08-2025
- STEM 03-04-2025
- Dividend Yield
- CUE N/A
- STEM N/A
- EPS Growth
- CUE N/A
- STEM N/A
- EPS
- CUE N/A
- STEM N/A
- Revenue
- CUE $9,532,000.00
- STEM $144,584,000.00
- Revenue This Year
- CUE $73.11
- STEM $125.17
- Revenue Next Year
- CUE $11.02
- STEM $22.49
- P/E Ratio
- CUE N/A
- STEM N/A
- Revenue Growth
- CUE 149.53
- STEM N/A
- 52 Week Low
- CUE $0.45
- STEM $0.30
- 52 Week High
- CUE $2.26
- STEM $2.23
- Technical
- Relative Strength Index (RSI)
- CUE 33.15
- STEM 42.15
- Support Level
- CUE $0.95
- STEM $0.41
- Resistance Level
- CUE $1.03
- STEM $0.49
- Average True Range (ATR)
- CUE 0.08
- STEM 0.04
- MACD
- CUE 0.01
- STEM 0.00
- Stochastic Oscillator
- CUE 3.85
- STEM 24.00
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.